STEMGEN Trademark

Trademark Overview

On Monday, December 18, 2006, a trademark application was filed for STEMGEN with the United States Patent and Trademark Office. The USPTO has given the STEMGEN trademark a serial number of 79037493. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, April 10, 2019. This trademark is owned by Stemgen S.p.A.. The STEMGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Services in the field of science and technology, namely, clinical research in the field of brain oncology and degenerative diseases and computer technology associated therewith; scientific medical and pharmacological research services in the field of brain oncology, excluding pharmaceutical research concerning blood cell production; research and development services in the field of biotechnology in the area of DNA and recombinant proteins; research and technology consultation services regarding diagnostic methods applied to brain oncology and degenerative diseases
stemgen

General Information

Serial Number79037493
Word MarkSTEMGEN
Filing DateMonday, December 18, 2006
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, April 10, 2019
Registration Number3602603
Registration DateTuesday, April 7, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 14, 2008

Trademark Statements

Certificate of Correction for RegistrationIn the statement, column 1, line 10, "filed" should be deleted, and, "field" should be inserted.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the fancy word "stemgen" in which the letter "s" is comprised in an ellipse which bears an upper sphere, the sign "gen" is slightly shaded with respect to the sign "stem", and a line is drawn immediately under the sign "temgen".
Goods and ServicesServices in the field of science and technology, namely, clinical research in the field of brain oncology and degenerative diseases and computer technology associated therewith; scientific medical and pharmacological research services in the field of brain oncology, excluding pharmaceutical research concerning blood cell production; research and development services in the field of biotechnology in the area of DNA and recombinant proteins; research and technology consultation services regarding diagnostic methods applied to brain oncology and degenerative diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 4, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStemgen S.p.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMilano I20145
IT
Party NameStemgen S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressI-20145 Milano
IT
Party NameStemgen S.p.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressI-20145 Milano
IT

Trademark Events

Event DateEvent Description
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 10, 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, April 10, 2019REGISTERED-SEC.71 ACCEPTED
Tuesday, March 26, 2019TEAS SECTION 71 RECEIVED
Saturday, April 7, 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Tuesday, May 23, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2017INTERNATIONAL REGISTRATION RENEWED
Thursday, April 2, 2015NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, April 2, 2015REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, April 1, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 24, 2015TEAS SECTION 71 & 15 RECEIVED
Friday, January 11, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 22, 2009FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 22, 2009FINAL DISPOSITION PROCESSED
Tuesday, July 7, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, July 1, 2009CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, June 25, 2009ASSIGNED TO PARALEGAL
Monday, May 18, 2009TEAS SECTION 7 REQUEST RECEIVED
Tuesday, April 7, 2009REGISTERED-PRINCIPAL REGISTER
Friday, February 27, 2009EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, November 14, 2008NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, November 11, 2008EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, October 30, 2008NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, October 30, 2008NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 14, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 24, 2008NOTICE OF PUBLICATION
Friday, September 12, 2008EXAMINERS AMENDMENT MAILED
Friday, September 12, 2008CORRESPONDENCE MAILED
Wednesday, September 10, 2008TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 11, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 11, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 11, 2008EXAMINER'S AMENDMENT ENTERED
Thursday, September 11, 2008EXAMINERS AMENDMENT -WRITTEN
Monday, May 5, 2008ASSIGNED TO EXAMINER
Monday, March 10, 2008FINAL REFUSAL MAILED
Friday, March 7, 2008FINAL REFUSAL WRITTEN
Thursday, December 27, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, December 27, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 21, 2007ASSIGNED TO LIE
Tuesday, November 13, 2007PAPER RECEIVED
Friday, June 29, 2007REFUSAL PROCESSED BY IB
Friday, June 8, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 8, 2007REFUSAL PROCESSED BY MPU
Thursday, June 7, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 6, 2007NON-FINAL ACTION WRITTEN
Monday, June 4, 2007ASSIGNED TO EXAMINER
Monday, June 4, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, May 31, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

stemgen research services field oncology technology brain diseases degenerative applied area